631 related articles for article (PubMed ID: 15061349)
1. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases: their biological functions and clinical implications.
Hijova E
Bratisl Lek Listy; 2005; 106(3):127-32. PubMed ID: 16026148
[TBL] [Abstract][Full Text] [Related]
3. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
[TBL] [Abstract][Full Text] [Related]
4. [Matrix metalloproteinases and atherosclerosis. Therapeutic aspects].
Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
Ann Biol Clin (Paris); 2003; 61(2):147-58. PubMed ID: 12702469
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of matrix metalloproteinase inhibitors in atherosclerosis.
George SJ
Expert Opin Investig Drugs; 2000 May; 9(5):993-1007. PubMed ID: 11060722
[TBL] [Abstract][Full Text] [Related]
6. [Matrix metalloproteinases and their tissue inhibitors].
Trojanek J
Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
[TBL] [Abstract][Full Text] [Related]
7. [Extracellular matrix -- from basic research to clinical significance. An overview with special consideration of matrix metalloproteinases].
Hamacher S; Matern S; Roeb E
Dtsch Med Wochenschr; 2004 Sep; 129(38):1976-80. PubMed ID: 15375740
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of matrix metalloproteinases and TIMPs.
Nagase H; Visse R; Murphy G
Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
[TBL] [Abstract][Full Text] [Related]
9. Role of metalloproteinases and tissue inhibitors of metalloproteinases during cardiopulmonary bypass in rats.
Guenzinger R; Lahm H; Wottke M; Lange R
ASAIO J; 2012; 58(3):204-11. PubMed ID: 22395114
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
Raffetto JD; Khalil RA
Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
[TBL] [Abstract][Full Text] [Related]
11. Granulocytes in coronary thrombus evolution after myocardial infarction--time-dependent changes in expression of matrix metalloproteinases.
Li X; de Boer OJ; Ploegmaker H; Teeling P; Daemen MJ; de Winter RJ; van der Wal AC
Cardiovasc Pathol; 2016; 25(1):40-6. PubMed ID: 26490693
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinases and atherosclerotic plaque instability.
Loftus IM; Naylor AR; Bell PR; Thompson MM
Br J Surg; 2002 Jun; 89(6):680-94. PubMed ID: 12027977
[TBL] [Abstract][Full Text] [Related]
13. Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure?
Creemers EE; Cleutjens JP; Smits JF; Daemen MJ
Circ Res; 2001 Aug; 89(3):201-10. PubMed ID: 11485970
[TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
15. TIMPs as multifacial proteins.
Lambert E; Dassé E; Haye B; Petitfrère E
Crit Rev Oncol Hematol; 2004 Mar; 49(3):187-98. PubMed ID: 15036259
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
Varghese S
Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
[TBL] [Abstract][Full Text] [Related]
17. An alternate perspective on the roles of TIMPs and MMPs in pathology.
Moore CS; Crocker SJ
Am J Pathol; 2012 Jan; 180(1):12-6. PubMed ID: 22033229
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases and diabetic vascular complications.
Kadoglou NP; Daskalopoulou SS; Perrea D; Liapis CD
Angiology; 2005; 56(2):173-89. PubMed ID: 15793607
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in hamster aortic atherosclerosis: correlation with in-situ zymography.
Faia KL; Davis WP; Marone AJ; Foxall TL
Atherosclerosis; 2002 Feb; 160(2):325-37. PubMed ID: 11849655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]